See every side of every news story
Published loading...Updated

Melanoma Survivor Shares Story to Encourage Pittsburghers to Prioritize Skin Health

UNITED STATES, JUL 18 – A genetically modified herpesvirus combined with nivolumab shrank tumors by 30% in one-third of advanced melanoma patients, with FDA review expected by July 2025.

Summary by WTAE
Melanoma, the most serious skin cancer, claims thousands of lives a year, with men dying at a higher rate because of delayed detection and treatment.

4 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

cancernetwork.com broke the news in on Friday, July 18, 2025.
Sources are mostly out of (0)

Similar News Topics